Antibiotic misuse in medium-sized Swiss hospitals

Swiss Medical Weekly

Volumn 134, Issue 33-34, 2004, Pages 481-485

  Bugnon Reber, A V ^a   De Torrente A ^a   Troillet, N ^b,i   Genné, Daniel ^a,g   Christin, L ^c   Chuard, C ^d   Cometta, A ^e   Erard, P ^f   Schubarth, P ^h   Zwahlen, A ^j  

^a Hopital de la Chaux de Fonds   (Switzerland)

^b Ctrl Inst of the Valais Hospitals   (Switzerland)

^c Hôpital de zone de Nyon   (Switzerland)

^d Hopital Cantonal de Fribourg   (Switzerland)

^e Hôpital de Zone d'Yverdon   (Switzerland)

^f Hopital Pourtales Neuchatelois   (Switzerland)

^g Hop ville de la Chaux de Fonds   (Switzerland)

^h Hôpital Régional Delémont   (Switzerland)

ⁱ Institut Central des Hopitaux Valaisans   (Switzerland)

^j Hôpital de Zone de St Loup   (United States)

more..

Author keywords

Antibiotic costs; Antibiotic misuse; Swiss hospitals

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; GLYCOPEPTIDE; MACROLIDE; METRONIDAZOLE; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CONSULTATION; COST CONTROL; DRUG COST; DRUG INDICATION; DRUG MISUSE; DRUG USE; HOSPITAL; HOSPITAL PATIENT; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MONEY; PRESCRIPTION; SWITZERLAND;

EID: 4644308086     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mc Gowan JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-48.
2. Murray BE. Can antibiotic resistance be controlled? N Engl J Med 1994;330:1229-30.
3. Joshi N, Milfred D. The use and misuse of new antibiotics: A perspective. Arch Intern Med 1995;155:569-77.
4. Gold HS, Moellering RC. Antimicriobal-drug resistance. N Engl J Med 1996;335:1445-53.
5. Neu HC. The crisis in antibiotic resistance. Science 1992;257:1064-72.
6. Parret T, Schneider R, Rime B, Saghafi L, Pannatier A, Francioli P. Evaluation de l'utilisation des antibiotiques: une étude prospective dans un centre hospitalier universitaire. Schweiz Med Wschr 1993;123:403-13.
7. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996;124:884-90.
8. Moss F, McSwiggan DA, McNicol MW, Miller DI. Survey of antibiotic prescribing in a district general hospital:pattern of use. Lancet 1981;15:349-52.
9. Massari P, Czernichow P, Manouvrier C, Lecomte F, Auger MP, Humbert G, et al. Modalités d'utilisation et évaluation de l'antibiothé rapie. Etude dans quatre services hospitaliers. Rev Epidém Santé publ 1993;41:161-8.
10. Lew DP, Garbino J, Gerber AU, Sudre Ph. Use of antimicrobials in Swiss hospitals. Drugs 1996;52:88-91.
11. Dunagan WC, Woodward RS, Medoff G, Gray JL, Casabar E, Lawrenz C, et al. Antibiotic misuse in two clinical situations: positive blood culture and administration of aminoglycosides. Rev Infect Dis 1991;13:405-12.
12. Wilkins EG, Hickey MM, Khoo S, Hale AD, Umasankar S, Thomas P, et al. Northwood Park Infection Control Consultation Service. Park II. Contribution of the service to patient management: an analysis of results between September 1987 and July 1990. J Infect 1991;23:57-63.
13. Fraser GL, Stogsdill P, Dickens JD, Wennberg DE, Smith RP, Prato BS. Antibiotic optimization: an evaluation of patient safety and economic outcomes. Arch Intern Med 1997;157:1689-94.
14. Davey P. Antibiotic policies: Economics and effectiveness from a UK perspective. Drugs 1996;52:83-7.
15. Moleski RJ, Andriole VT. Role of the infectious disease specialist in containing costs of antibiotics in the hospital. Rev Infect Dis 1986;8:488-93.
16. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000;101:2916-21.
17. Finnish Study Group for Antimicriobial Resistance. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997;337:491-2.
18. Duncan RA. Controlling use of antimicrobial agents. Infect Control Hosp Epidemiol 1997;18:260-6.
19. Pechère JC. Bacterial resistance: new threats, new challenges. Supp Care Cancer 1993;1:124-9.
20. White AC, Armar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of Requiring Prior Authorization for Selected Antimicrobials: Expenditures, Susceptibilities and Clinical Outcomes. Clin Infect Dis 1997;25:230-9.
21. Soumerai SB, Avorne J, Taylor WC, Wessels M, Maher D, Hawley SL. Improving choice of prescribed antibiotics through concurrent reminders in an educational order form. Medical Care 1993;31:552-8.
22. Erard P, Ruedi B. Importance des maladies infectieuses et rôle de l'infectiologue dans un hôpital non universitaire. Rev Med Suisse Romande 1993;113:901-8.